• Home
  • Search
  • Plasma Pentraxin 3 is a More Potent Predictor of Endothelial Dysfunction than High-Sensitive C-Reactive Protein
  • Cite Icon48
  • https://doi.org/10.1536/ihj.13-253Copy DOI Icon

Plasma Pentraxin 3 is a More Potent Predictor of Endothelial Dysfunction than High-Sensitive C-Reactive Protein

Show More
  • Abstract
  • Literature Map
  • References
  • Citations
  • Similar Papers
Abstract

An inflammatory response is a key event for endothelial dysfunction. Pentraxin 3 (PTX3) is an inflammatory protein produced at inflammation sites such as leukocytes and vascular endothelial cells. Here, we compared the relationships between endothelial function assessed by flow-mediated dilation (FMD), and the levels of plasma PTX3 and high-sensitive C-reactive protein (hsCRP), another inflammatory protein of the pentraxin family. Levels of FMD, PTX3 and hsCRP were measured twice within 6 to 8 months and retrospectively analyzed in 36 patients with coronary artery disease. We examined the associations between the values of FMD and the levels of PTX3 and hsCRP at the first measurement, and between the change ratios (second value/first value) of these parameters. Univariate linear regression analysis showed significantly negative correlations between FMD values and PTX3 and hsCRP levels at the first measurement, and significant associations with taking statins or calcium antagonists. Multivariate linear stepwise regression analysis identified PTX3 levels and taking statins and calcium antagonists as independent factors for endothelial function. The change ratio of FMD correlated more closely with that of PTX3 than of hsCRP (r = -0.446, P = 0.006 versus r = -0.330, P = 0.050). Significantly more patients with decreased FMD values had increased levels of PTX3 than those of hsCRP at the second measurement compared with the fi rst measurement. Furthermore, the ratio of patients with increased PTX3, but not increased hsCRP, was significantly reduced among those with increased, rather than decreased, FMD values. Endothelial dysfunction might be more accurately predicted by plasma PTX3 levels than by serum hsCRP levels.

Similar Papers
  • Research Article
  • Citations42

Plasma Pentraxin 3, but not High-sensitivity C-reactive Protein, is a Useful Inflammatory Biomarker for Predicting Cognitive Impairment in Elderly Hypertensive Patients

  • Mar 04, 2010
  • The Journals of Gerontology: Series A
  • Yuichiro Yano +8
  • Research Article
  • Citations5

Association of Plasma Pentraxin-3 Levels with Retinopathy and Systemic Factors in Diabetic Patients.

  • Jul 23, 2018
  • Metabolic Syndrome and Related Disorders
  • Füsun Erdenen +9
  • Peer Review Report

Decision letter: Regulation of inflammation and protection against invasive pneumococcal infection by the long pentraxin PTX3

  • Jun 20, 2022
  • Sebastian Weis +1
  • Research Article
  • Citations2

Differing Behavior of Plasma Pentraxin3 and High-Sensitive CRP at the Very Onset of Myocardial Infarction with ST-segment Elevation

  • Jan 01, 2013
  • Angiology: Open Access
  • Tetsuo Yamasaki
  • Research Article
  • Citations25

Pentraxin 3 as a Novel Biomarker of Inflammation in Chronic Obstructive Pulmonary Disease

  • Oct 11, 2014
  • Inflammation
  • Ozlem Kar Kurt +3
  • Abstract
  • Citations4

Tissue directed recruitment of mononuclear cells to the lung using a recombinant adenovirus expressing murine RANTES

  • Sep 01, 1994
  • Cytokine
  • Todd A Braciak +7
  • Research Article
  • Citations14

Plasma Pentraxin 3 May Be a More Sensitive Marker of Inflammatory Response Than High-Sensitivity C-Reactive Protein After Bare-Metal Stent Compared to Drug-Eluting Stent Implantation

  • Feb 15, 2013
  • Journal of Interferon & Cytokine Research
  • Bartosz Hudzik +7
  • Research Article
  • Citations3

The Effect of Intracoronary Stem Cell Injection on Markers of Leukocyte Activation in Acute Myocardial Infarction

  • Feb 01, 2015
  • Cardiology Research
  • Ragnhild Helseth +5
  • Abstract
  • Citations1

Pentraxin 3 As a Novel Diagnostic and Prognostic Biomarker for Acute GvHD and Fungal Infections in Adult Allogeneic HSCT Recipients

  • Dec 02, 2016
  • Blood
  • Raffaella Greco +19
  • Abstract
  • Citations1

SAT0364 Pentraxin 3 as Biomarker in Assessment of Disease Activity in Takayasu Arteritis

  • Jun 01, 2016
  • Annals of the Rheumatic Diseases
  • P.K Devarasetti +3
  • PDF
  • Research Article
  • Citations53

Human Pentraxin 3 (PTX3) as a Novel Biomarker for the Diagnosis of Pulmonary Arterial Hypertension

  • Sep 21, 2012
  • PLoS ONE
  • Yuichi Tamura +13
  • Research Article
  • Citations19

Cardiorespiratory fitness does not alter plasma pentraxin 3 and cortisol reactivity to acute psychological stress and exercise

  • Oct 11, 2013
  • Applied Physiology, Nutrition, and Metabolism
  • Chun-Jung Huang +5
  • Abstract

OP04 Circulating levels of the long pentraxin PTX3, but not hepatocyte derived C-reactive protein, correlate with severity following human acute liver injury

  • Sep 01, 2010
  • Gut
  • Douglas A Craig +6
  • Research Article

Study on the plasma pentraxin 3 levels in patients with acute coronary syndrome

  • Aug 01, 2008
  • 中国综合临床
  • Raorao Zhang +3
  • Research Article
  • Citations40

High pentraxin-3 plasma levels associate with thrombocytopenia in acute Puumala hantavirus-induced nephropathia epidemica

  • Sep 07, 2011
  • European Journal of Clinical Microbiology & Infectious Diseases
  • T K Outinen +9
Cactus Communications logo

Copyright 2026 Cactus Communications. All rights reserved.